Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review.
Roos
Yvo
Y
the Department of Neurology, Academic Medical Center, Amsterdam, the Netherlands. Y.B.Roos@amc.uva.nl
Rinkel
Gabriel
G
Vermeulen
Marinus
M
Algra
Ale
A
van Gijn
Jan
J
D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000209:etiology; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology; D016017:Odds Ratio; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D018570:Risk Assessment; D055502:Secondary Prevention; D013345:Subarachnoid Hemorrhage / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents